Future Directions in Clinical Research of NSCLC

 

The aim of this evaluation form is to gain your feedback, in order to maintain high educational standards and provide a reference for continuous improvement. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did your undertaking of this E-Learning module allow you to become familiar with novelties in the molecular classification of non-small-cell lung cancer evolving from deeper understanding in molecular biology of cancer? (1-not at all; 5-yes absolutely)

2. Did your undertaking of this E-Learning module allow you to gain knowledge on developmental therapeutics for heterogeneous group of tumours that belong to an old term category of non-small-cell lung cancer? (1-not at all; 5-yes absolutely)

3. Did your undertaking of this E-Learning module allow you to understand future research directions and potentials for changing the clinical landscape in non-small-cell lung cancer by novel targeted agents and immunotherapeutics? (1-not at all; 5-yes absolutely)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-absolutely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: